Interest in MTH1 as an oncology target has re-emerged recently and its inhibition has been suggested to be beneficial in a wide range of tumours.[7,8] We discuss here a series of substrate and fragment binding modes observed with the MTH1 protein in their protein structures. This evidence concerns the gene NUDT1 and neoplasm.